Historic first: surgeons transplant pig liver and kidneys into human body

Historic first: surgeons transplant pig liver and kidneys into human body

Surgeons have for the first time simultaneously transplanted a genetically modified pig liver and two kidneys into a brain-dead human. The organs functioned in the body for nearly five days, marking a significant milestone in xenotransplantation research.

Технологии

In a landmark medical achievement, surgeons have successfully transplanted a genetically modified pig liver along with two kidneys into a brain-dead human patient simultaneously — a procedure never before attempted. The organs remained functional within the human body for close to five days.

This breakthrough represents a major step forward in xenotransplantation, the science of transplanting animal organs into humans. Researchers have long viewed genetically engineered pig organs as a potential solution to the chronic global shortage of donor organs, and this combined multi-organ transplant pushes that frontier further than ever before.

The genetic modifications made to the pig organs are designed to reduce the risk of rejection by the human immune system, a key obstacle that has historically prevented such transplants from succeeding. The fact that the liver and kidneys continued to function for nearly five days in the human body is considered a promising sign for future research and, eventually, clinical applications.

Scientists and medical professionals are cautiously optimistic about the implications of this procedure. While the patient was brain-dead and the experiment was conducted in a controlled research setting, the results provide critical data about how human bodies respond to multi-organ xenotransplants over an extended period.

The achievement is seen as a historic milestone in medical science, bringing the possibility of using animal organs to save human lives one step closer to reality. Researchers say further experiments will be needed before such procedures could be considered for living patients, but this first-of-its-kind operation has opened a new chapter in transplant medicine.

Открыть в приложении →